ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2021 American Transplant Congress

    Pilot Study for the Use of Shortened Preemptive Therapy with Glecaprevir/pibrentasvir (g/p) and Ezetimibe in Hepatitis C Seronegative Solid Organ Transplant Recipients (Kidney and Heart) of Hepatitis C Viremic Donors

    B. Aqel1, H. Khamash2, A. Moss3, D. E. Steidley4, R. C. Dickson1

    1Gastroenterology and Hepatology, Mayo Clinic, Phoenix, AZ, 2Nephrology and Hypertension, Mayo Clinic, Phoenix, AZ, 3Transplant Surgery, Mayo Clinic, Phoenix, AZ, 4Cardiology, Mayo Clinic, Phoenix, AZ

    *Purpose: This prospective study aims to assess the efficacy of preemptive therapy with eight days of a combination of direct-acting antivirals (DAAs) (Mavyret) (Pibrentasvir /Glecaprevir)…
  • 2021 American Transplant Congress

    Survival After Heart Transplant vs. Simultaneous Heart Kidney Transplant by Degrees of Renal Dysfunction at Engraftment in the United States: A Multivariable Analysis

    S. M. Riad1, M. Aljuhani1, S. Jackson2, T. Alexy1, H. Wadie3, C. Martin1, R. Kandaswamy4

    1Medicine, University of Minnesota, Eden Prairie, MN, 2Complex Care Analytics, Fairview Health Services, Minneapolis, MN, 3Transplant, Mayo Clinic, Jacksonville, FL, 4Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: There has been a rising trend for utilizing kidneys in heart transplant candidates with different renal dysfunction degrees without established criteria to address this…
  • 2021 American Transplant Congress

    High Interest, Low Payoff: Understanding Opportunities for Intervention for Those Exploring but Not Pursuing Paired Kidney Donation

    A. D. Waterman1, E. H. Wood1, A. Thomas2

    1UCLA David Geffen School of Medicine, Los Angeles, CA, 2Johns Hopkins, Baltimore, MD

    *Purpose: In 2016, the National Kidney Registry (NKR) established an online donor screening portal (DASH) to manage and track individuals interested in kidney paired donation…
  • 2021 American Transplant Congress

    Reduction in Medication Errors at Discharge in the Transplant Population via Use of Novel Pharmacist / Nursing Dual Check System

    M. Norris, S. Witek, C. Whritenour, K. Sigafus, C. Chiang, C. Sammons, D. Naveiro, A. Paredes, E. Perez-Ngai, M. Kaminski, R. Westmoreland, G. Malat

    Hospital of the University of Pennsylvania, Philadelphia, PA

    *Purpose: Medication errors are of great concern due to the risk for patient and allograft injury. The aim of this study was to evaluate the…
  • 2021 American Transplant Congress

    Association Between Donor-Recipient Genetic Matching and Acute Rejection in Kidney Transplantation

    R. Cao1, V. Arthur2, J. Chen2, B. Keating2, C. Dorr3, D. Schladt3, G. Onyeaghala3, R. Mannon4, A. Matas1, R. Remmel1, N. Pankratz1, B. Wu1, W. Oetting1, P. Jacobson1, A. Israni3, W. Guan1

    1University of Minnesota, Minneapolis, MN, 2University of Pennsylvania, Philadelphia, PA, 3Hennepin Healthcare Research Institute, Minneapolis, MN, 4University of Nebraska, Omaha, NE

    *Purpose: In this study we carried out a genome-wide association study (GWAS) between donor-recipient matching scores at individual SNP level and Acute rejection (AR) in…
  • 2021 American Transplant Congress

    Properties of Regulatory B Cells Suppressing B Cells

    Q. Fu1, K. Lee2, K. Deng2, G. Huai2, C. Rickert2, H. Yang1, C. LeGuern2, S. Deng1, J. F. Markmann2

    1Organ Transplantation Center, Sichuan Provincial People's Hospital, University of Electronic Sciences and Technology of China, Chengdu, China, 2Center for Transplantation Sciences, MGH, Boston, MA

    *Purpose: Our previous study showed that TLR-Bregs, regulatory B cells generated in vitro through TLR activation, suppressed naïve B cell proliferation triggered by a mitogen…
  • 2021 American Transplant Congress

    Enhancement of Regulatory T Cell Therapies by Biomimetic Nanofiber Matrices on Single Cells

    L. A. Fraser1, S. Lee1, Y. Sambandam2, J. He2, X. Huang2, D. Z. Ivancic2, J. Mathew2, Z. J. Zhang2, J. R. Leventhal2, L. Gallon2, S. I. Stupp1

    1Simpson Querrey Institute, Northwestern, Chicago, IL, 2Surgery – Comprehensive Transplant Center, Northwestern, Chicago, IL

    *Purpose: Here we report a new method to create an artificial and biodegradable matrix of biomimetic nanofibers on single cells with the goal of enhancing…
  • 2021 American Transplant Congress

    Treg Lymphotoxin Engages Lymphotoxin Receptor on Cancer and Endothelial Cells to Promote Cancer Metastatic Migration: Mechanisms for Treg-Cancer Interactions

    W. Piao, R. Oakes, C. Paluskievicz, J. Christopher, J. Bromberg

    U Maryland, Baltimore, MD

    *Purpose: Treg immune suppression which is critical for transplant graft survival may also enhance tumor growth and metastases. Treg lymphotoxin (LTα1β2) may directly engage the…
  • 2021 American Transplant Congress

    IL-10 Signaling in T Cells Modulates Costimulation-independent Activation and is Essential for Transplant Tolerance Induction

    M. Iglesias Lozano1, D. Bibicheff1, M. Chicco2, A. Komin1, G. Brandacher1, G. Raimondi1

    1Plastic Surgery, Johns Hopkins University, Baltimore, MD, 2Frimley Health NHS Foundation Trust, London, United Kingdom

    *Purpose: Costimulation blockade (CoB)-based immunotherapy remains a very promising approach for better management of transplant recipients. Understanding the mechanisms that impact the efficacy of CoB…
  • 2021 American Transplant Congress

    Selective Bcl-2 Inhibition to Deplete Hematopoietic Stem Cells in Bone Marrow Niche: A Novel Approach to Promote Mixed Chimerism

    T. Hirose1, H. Sasaki1, G. Lassiter1, D. Ma1, T. Oura1, A. Dehnadi1, A. Cosimi1, P. Cippa2, T. Fehr2, T. Kawai1

    1Center for Transplantation Sciences, Massachusetts General Hospital, Boston, MA, 2Institute of Physiology, University of Zurich, Zurich, Switzerland

    *Purpose: A recent murine study has shown that successful mixed chimerism is achievable without myelosuppressive treatments by Bcl-2 inhibition. However, the mechanism by which selective…
  • « Previous Page
  • 1
  • …
  • 103
  • 104
  • 105
  • 106
  • 107
  • …
  • 139
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences